The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.
Translating Research Into Practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment Recommendations
Abstract
Beginning in 1992, the Agency for Health Care Policy and Research and the National Institute of Mental Health funded the Schizophrenia Patient Outcomes Research Team (PORT) to develop and disseminate recommendations for the treatment of schizophrenia based on existing scientific evidence. These Treatment Recommendations, presented here in final form for the first time, are based on exhaustive reviews of the treatment outcomes literature (previously published in Schizophrenia Bulletin, Vol. 21, No. 4, 1995) and focus on those treatments for which there is substantial evidence of efficacy. The recommendations address antipsychotic agents, adjunctive pharmacotherapies, electroconvulsive therapy, psychological interventions, family interventions, vocational rehabilitation, and assertive community treatment/intensive case management. Support for each recommendation is referenced to the previous PORT literature reviews, and the recommendations are rated according to the level of supporting evidence. The PORT Treatment Recommendations provide a basis for moving toward "evidence-based" practice for schizophrenia and identify both the strengths and limitations in our current knowledge base.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is, therefore, likely that discontinuation studies employing linear dose reductions,74,83,84,86,87 as recommended in some older guidelines,94 will be more likely to induce withdrawal reactions (including, potentially, withdrawal psychosis) because reductions in D2 antagonism become increasingly large, causing greater likelihood of dopaminergic rebound.”
From A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse (2021) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,825
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,021
Family Interventions for Schizophrenia
Dixon, L. B., & Lehman, A. F. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.631 · Cited by 394
Self-citationPsychopharmacologic Treatment of Schizophrenia
Kane, J. M., & Marder, S. R. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.287 · Cited by 271
Vocational Rehabilitation in Shizophrenia
Lehman, A. F. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.645 · Cited by 239
Self-citationAssertive Community Treatment and Case Management for Schizophrenia
Scott, J. E., & Dixon, L. B. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.657 · Cited by 226
Conventional Antipsychotic Medications for Schizophrenia
Dixon, L. B., Lehman, A. F., & Levine, J. A. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.567 · Cited by 182
Self-citationClozapine: Efficacy and Safety
Buchanan, R. W. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.579 · Cited by 161
Psychological Interventions for Schizophrenia
Scott, J. E., & Dixon, L. B. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.621 · Cited by 134
Risperidone: Efficacy and Safety
Umbricht, D., & Kane, J. M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.593 · Cited by 73
Research works printed but not linked: 4
- Kane, J.M. Schizophrenia. New England Journal of Medicine, 334:34-41, 1996.
- Kane, J.M., and Marder, S.R. Psychopharmacologic treat- ment of schizophrenia. Schizophrenia Bulletin, 19(2): 287-302, 1993.
- Lehman, A.F. Vocational rehabilitation in schizophrenia. Schizophrenia Bulletin, 21(4):645-656, 1995.
- Zito, J.M. Psychotherapeutic Drug Manual. 3rd ed. New York, NY: John Wiley & Sons, 1994.
Cited by
Sorted by citations
Items 501–600 of 900
Kinnaman, J. E. S., & Bellack, A. S. (2012) · Wiley eBooks · doi:10.1002/9781118470886.ch10 · Cited by 15
Italian Families and Family Interventions
CASACCHIA, M., & Roncone, R. (2014) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000149 · Cited by 14
Autism Spectrum Disorders: Comorbid Psychopathology and Treatment
Mohiuddin, S. S., Bobak, S., Gih, D. E., & Ghaziuddin, M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8065-6_29 · Cited by 14
Family Intervention in First Episode Psychosis
Lepage, S. J. M. (2005) · International Journal of Systemic Therapy · doi:10.1300/j085v16n03_07 · Cited by 14
Drug Class Review: Atypical Antipsychotic Drugs
McDonagh, M. S., Peterson, K., Carson, S., Fu, R., & Thakurta, S. (2010) · Cited by 14
Taylor, L. C., Taske, N., Swann, C., & Waller, S. (2007) · Cited by 14
Recent developments in psychosocial treatments for schizophrenic patients
Shean, G. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.817 · Cited by 15
Mahadun, P., & Marshall, M. (2008) · Psychiatric Bulletin · doi:10.1192/pb.bp.107.015875 · Cited by 14
Adapting to Psychiatric Disability and Needs for Home- and Community-Based Care
Green, C. A., Vuckovic, N. H., & Firemark, A. J. (2002) · Mental Health Services Research · doi:10.1023/a:1014045125695 · Cited by 14
Open access to innovative drugs: treatment substitutions or treatment expansion?
McCombs, J. S., Mulani, P. M., & Gibson, P. J. (2004) · PubMed Central · Cited by 14
Gottdiener, W. H., & Haslam, N. (2003) · Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry · doi:10.1521/jaap.31.1.191.21927 · Cited by 14
Wiley-Exley, E., Domino, M. E., Ricketts, T. C., Cuddeback, G. S., Burns, B. J., & MORRISSEY, J. P. (2013) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390313494170 · Cited by 13
Thompson, J. L., Holloway, K., Karyczak, S., Serody, M. R., Lane, I. A., Ellison, M. L., Gill, K. J., Davis, M., & Mullen, M. G. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000033 · Cited by 13
Systematic Review of EBPs for SMI in Rural America
Weaver, A., Capobianco, J., & Ruffolo, M. C. (2015) · Journal of Evidence-Informed Social Work · doi:10.1080/15433714.2013.765815 · Cited by 13
Spaulding, W. D., Montague, E., Avila, A., & Sullivan, M. E. (2016) · Evidence-based practices in behavioral health · doi:10.1007/978-3-319-40537-7_1 · Cited by 14
The Psychotherapy of Schizophrenia: Its Place in the Modern World*
Silver, A.-L. S. (2003) · Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry · doi:10.1521/jaap.31.2.325.22117 · Cited by 13
Efficacy of β-blocker supplementation for schizophrenia: a systematic review of randomized trials
Wahlbeck, K., Cheine, M. V., Gilbody, S. M., & Ahonen, J. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00069-9 · Cited by 13
Optimizing pharmacotherapy of schizophrenia: Tools for the psychiatrist
Constantine, R. J., Richard, S. M., Surles, R. C., Medvedeff, D., Dewan, N. A., Mann, L., Williamson, J. M., & Tandon, R. (2006) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629408 · Cited by 13
Rabinowitz, J., Bromet, E. J., Lavelle, J., Hornak, K. J., & Rosen, B. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.1.87 · Cited by 13
Atypical and typical neuroleptics in acute schizophrenia and related delusional disorders
Gäebel, W., Riesbeck, M., Janssen, B., Schneider, F. W., Held, T., Mecklenburg, H., & Sa�, H. (2003) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-003-0422-9 · Cited by 13
Silver, A.-L. S., & Larsen, T. K. (2003) · Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry · doi:10.1521/jaap.31.1.1.21937 · Cited by 13
Psychosocial rehabilitation: Approach of choice for those with serious mental illnesses
Farkas, M. D., Jansen, M. A., & Penk, W. E. (2007) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2007.09.0143 · Cited by 13
Socioeconomic factors influencing antipsychotic prescription for schizophrenia inpatients in China
Xue, Q., Xiong, X., Feng, Y., Yao, L., Chen, S., & Li, X. (2013) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000024 · Cited by 12
Community Adherence to Schizophrenia Treatment and Safety Monitoring Guidelines
Keller, W. R., Fischer, B. A., McMahon, R. P., Meyer, W. A., Blake, M., & Buchanan, R. W. (2013) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000093 · Cited by 12
Surviving in Psychiatry as a Systemic Therapist
Bertrando, P. (2009) · Australian and New Zealand Journal of Family Therapy · doi:10.1375/anft.30.3.160 · Cited by 12
Inside the Black Box: The Importance of Monitoring Treatment Implementation
Essock, S. M., Covell, N. H., & Weissman, E. M. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007107 · Cited by 12
Pollice, R., Bianchini, V., Conti, C., Mazza, M., Roncone, R., & CASACCHIA, M. (2010) · European Journal of Inflammation · doi:10.1177/1721727x1000800311 · Cited by 12
Managing Schizophrenia during the Stable Phase: Is There Consensus among Practice Guidelines?
Bhanji, N. H., & Tempier, R. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700112 · Cited by 12
Gioia, D. (2007) · Best practices in mental health · doi:10.70256/538553napgcz · Cited by 12
Michele, V. D., Bolino, F., Mazza, M., Roncone, R., & CASACCHIA, M. (2007) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00004607 · Cited by 12
Characteristics and Service Use Patterns of Nonelderly Medicare Beneficiaries With Schizophrenia
Yanos, P. T., Crystal, S., Kumar, R., & Walkup, J. T. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.12.1644 · Cited by 12
A Child‐inclusive Family Intervention in a Community Adult Mental Health Service
Cowling, V., & Garrett, M. (2012) · Australian and New Zealand Journal of Family Therapy · doi:10.1017/aft.2012.13 · Cited by 11
Chung, Y., Cui, Y., Kim, M., Kim, Y., Lee, K., & Chae, S. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116654698 · Cited by 11
Patterns of Treatment and Barriers to Care in Posttraumatic Stress Disorder
Thornicroft, G., Evans-Lacko, S. E., Koenen, K. C., Kovess–Masféty, V., Williams, D. R., & Kessler, R. C. (2018) · Cambridge University Press eBooks · doi:10.1017/9781107445130.009 · Cited by 12
Family Contact and the Management of Medication Non-adherence in Schizophrenia
Wilk, J. E., West, J. C., Marcus, S. C., Countis, L., Regier, D. A., & Olfson, M. (2008) · Community Mental Health Journal · doi:10.1007/s10597-008-9139-6 · Cited by 11
Bianchi, S., Bianchini, E., & Scanavacca, P. (2011) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-11-21 · Cited by 11
Low doses of antipsychotic drugs for hospitalized schizophrenia patients in East Asia: 2004 vs. 2001
Sim, K., Su, H. C., Fujii, S., Yang, S., Chong, M., Si, T., He, Y. L., Chung, E. K., Chan, Y. H., Shinfuku, N., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009280 · Cited by 11
Examining the Influence of Clinician Decision Making on Adherence to a Clinical Guideline
Falzer, P. R., Garman, D. M., & Moore, B. A. (2009) · Psychiatric Services · doi:10.1176/appi.ps.60.5.698 · Cited by 11
Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
Ren, X. S. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6637 · Cited by 11
Miller, L. S., & Martin, B. C. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007147 · Cited by 11
Making Progress in Mental Health Policy in Conservative Times: One Step at a Time
Goldman, H. H. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj042 · Cited by 11
Busch, A. B., Frank, R. G., Lehman, A. F., & Greenfield, S. F. (2006) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-006-0045-3 · Cited by 11
Self-citationUehara, E. S., Srebnik, D., & Smukler, M. (2003) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1023/a:1024080532651 · Cited by 11
Bengtsson‐Tops, A., & Hansson, L. I. (2003) · Scandinavian Journal of Caring Sciences · doi:10.1046/j.1471-6712.2003.00108.x · Cited by 11
Intervention Research in Psychosis: Prevention Trials
Lebowitz, B. D., & Pearson, J. L. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033475 · Cited by 11
Changes in the Costs of Treating Mental Health Disorders
Berndt, E. R. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422002-00005 · Cited by 11
Combination Treatments for Schizophrenia
Miller, A. L. (2004) · CNS Spectrums · doi:10.1017/s1092852900004363 · Cited by 11
Jacobs, S., Davidson, L., Steiner, J. L., & Hoge, M. A. (2002) · Community Mental Health Journal · doi:10.1023/a:1013964132596 · Cited by 11
Quality Enhancement Research Initiative in Mental Health
Fischer, E. P., Marder, S. R., Smith, G. R., Owen, R. R., Rubenstein, L. V., Hedrick, S. C., & Curran, G. M. (2000) · Medical Care · doi:10.1097/00005650-200006001-00008 · Cited by 11
Predictors of antipsychotic dose changes in the CATIE schizophrenia trial
Hermes, E. D. A., & Rosenheck, R. A. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.03.009 · Cited by 10
Incorporating clinical guidelines through clinician decision-making
Falzer, P. R., Moore, B. A., & Garman, D. M. (2008) · Implementation Science · doi:10.1186/1748-5908-3-13 · Cited by 10
Call for information, call for quality in mental health care
Lora, A. (2012) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796012000716 · Cited by 10
Conceptual Development of Mental Health Ontologies
Deogun, J. S., & Spaulding, W. D. (2009) · Studies in computational intelligence · doi:10.1007/978-3-642-05183-8_13 · Cited by 10
Adaptação transcultural de intervenções psicossociais na esquizofrenia
Villares, C. C. (2000) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462000000500018 · Cited by 10
Goh, Y.-L., Seng, K. H., Su, A. H. C., & Chua, H. C. (2011) · The Permanente Journal · doi:10.7812/tpp/11-017 · Cited by 10
Perspectives on Medical Research Involving Men in Schizophrenia and HIV-Related Protocols
Roberts, L. W., Warner, T. D., Hammond, K. A. G., & GEPPERT, C. M. A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj015 · Cited by 10
Owen, R. R., Thrush, C. R., Hudson, T. J., MALLORY, S. R., Fischer, E. P., Clardy, J. A., & Williams, D. K. (2002) · International Journal for Quality in Health Care · doi:10.1093/oxfordjournals.intqhc.a002611 · Cited by 10
Programas de Rehabilitación Psicosocial en la Atención Comunitaria a las Personas con Psicosis
Cases, J. G., & Abelardo, R. G. (2010) · Clínica y Salud · doi:10.5093/cl2010v21n3a8 · Cited by 10
Horvitz-Lennon, M. V., Alegria, M. M., & Normand, S. T. (2012) · Psychiatric Services · doi:10.1176/appi.ps.201100408 · Cited by 10
Andor, M., Dehelean, L., Romoșan, A. M., Buda, V. O., Radu, G., Căruntu, F. R., Bordejevic, A. D., Manea, M. M., Papavă, I., Bredicean, C. A., et al. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s186892 · Cited by 10
Duarte, E. A., de Mamani, A. W., Rosales, G. A., & Kymalainen, J. A. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 10
Eecke, W. V. (2003) · Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry · doi:10.1521/jaap.31.1.11.21929 · Cited by 10
An evaluation of a family psychoeducation program in community mental health.
de Groot, L., Lloyd, C., & King, R. (2003) · Psychiatric Rehabilitation Journal · doi:10.2975/27.2003.18.23 · Cited by 10
The Role of “Evidence” in Recovery from Mental Illness
Tanenbaum, S. J. (2006) · Health Care Analysis · doi:10.1007/s10728-006-0027-3 · Cited by 11
Goldman, M., Healy, D. J., Florence, T., Simpson, L., & Milner, K. K. (2003) · Community Mental Health Journal · doi:10.1023/b:comh.0000003015.68850.f2 · Cited by 10
The role of maintenance pharmacotherapy in achieving recovery from a first episode of schizophrenia
Tauscher‐Wisniewski, S., & Zipursky, R. B. (2002) · International Review of Psychiatry · doi:10.1080/0954026021000016923 · Cited by 10
Commentaries on the Schizophrenia Patient Outcomes Research Team (PORT) Studies
Kane, J. M., Hargreaves, W. A., Hester, T. W., Hogan, M. F., & Flynn, L. M. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033310 · Cited by 10
Crazy: A Father's Search Through America's Mental Health Madness
Pasco, S. D. (2007) · Psychiatric Services · doi:10.1176/appi.ps.58.2.280 · Cited by 10
Zwack, C. C., Haghani, M., & de Bekker-Grob, E. W. (2024) · Health Economics Review · doi:10.1186/s13561-023-00471-6 · Cited by 13
Satake, N., Hazama, K., Sono, T., Takahashi, M., & Ito, J. (2011) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/1745017901107010001 · Cited by 9
Fantini, G., Tibaldi, G., Rucci, P., Gibertoni, D., Vezzoli, M., Cifarelli, L., Tiraferri, R., & Munizza, C. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579601600010x · Cited by 9
The prevalence of delusional disorder in prison.
Tamburello, A. C., Bajgier, J., & Reeves, R. (2015) · PubMed · Cited by 9
Racial Disparities in the Treatment of Schizophrenia Spectrum Disorders: How Far Have We Come?
Menand, E. V., & Moster, R. L. (2021) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-021-00236-7 · Cited by 9
Saeed, S. A., Bloch, R. M., & Silver, S. B. (2015) · Psychiatric Quarterly · doi:10.1007/s11126-015-9372-4 · Cited by 9
Pharmacological strategies for relapse prevention in schizophrenia
Barnes, T. R. E., & Drake, R. (2007) · Psychiatry · doi:10.1016/j.mppsy.2007.07.002 · Cited by 9
Mental Health in the Mainstream of Public Policy: Research Issues and Opportunities
Goldman, H. H., Glied, S., & Alegria, M. M. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08040584 · Cited by 9
Outcomes of an Initial Set of Standardized Performance Measures for Inpatient Mental Health
Williams, T. L., Cerese, J., Cuny, J., & Sama, D. (2008) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(08)34050-1 · Cited by 9
Weiden, P. J., & Dixon, L. B. (1999) · Journal of Psychiatric Practice · doi:10.1097/00131746-199901000-00003 · Cited by 9
A Quality Improvement Process for Implementing the Texas Algorithm for Schizophrenia in Ohio
Dewan, N. A., Conley, D., Svendsen, D. P., Shon, S. P., Staup, J. R., Miller, A. L., Crismon, M. L., Rush, A. J., Trivedi, M. H., Skale, T., et al. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.12.1646 · Cited by 9
Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY) Part II
Pappadopulos, E. A., MacIntyre, J. C., Crismon, M. L., Findling, R. L., Malone, R. P., Derivan, A., Schooler, N. R., Sikich, L., Greenhill, L. L., Schur, S. B., et al. (2004) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.2.4.608 · Cited by 9
The Feasibility of Using Automated Data to Assess Guideline-Concordant Care for Schizophrenia
Hudson, T. J., Owen, R. R., Lancaster, A. E., & Mason, L. (1999) · Journal of Medical Systems · doi:10.1023/a:1020526327467 · Cited by 9
Taylor, P. J., & Estroff, S. E. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch30 · Cited by 9
Long-Term Adverse Effects of Novel Antipsychotics
Masand, P. S., & Gupta, S. (2000) · Journal of Psychiatric Practice · doi:10.1097/00131746-200011000-00002 · Cited by 9
Law, S., Andermann, L., Chow, W., Luo, X. W., & Wang, X. (2021) · Transcultural Psychiatry · doi:10.1177/13634615211000552 · Cited by 8
Critique of Falloon and the Optimal Treatment Project
Hayman‐White, K., & Happell, B. (2007) · International Journal of Mental Health Nursing · doi:10.1111/j.1447-0349.2006.00443.x · Cited by 8
Developing Roles and Skills in Community-Living Adults With Severe and Persistent Mental Illness
Schindler, V. P. (2008) · Occupational Therapy in Mental Health · doi:10.1080/01642120802055192 · Cited by 8
The use of Atypical antipsychotics in French psychiatric hospitals
Bret, M.-C., Bret, P., Pariente, A., & Reglat, A. F. (2007) · Pharmacy World & Science · doi:10.1007/s11096-007-9107-1 · Cited by 8
Use of Psychotropics and the Risk of Falls in Hospitalized Psychiatric Patients
Sano, T., Harada, M., Sugawara, T., Isaka, N., Masuoka, A., Mikami, A., Shimamori, Y., & Kurosawa, N. (2013) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.13-00003 · Cited by 8
Clinicians’ Reasons for Deviations from Recommended Dosing Practices for Antipsychotic Medications
Sernyak, M. J., & Rosenheck, R. A. (2007) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-007-0142-y · Cited by 8
Longitudinal impact of a collaborative care model on employment outcomes in bipolar disorder
Ryan, K. A., Eisenberg, D., Kim, H. M., Lai, Z., McInnis, M. G., & Kilbourne, A. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.052 · Cited by 8
Psychosocial treatments for schizophrenia
Bellack, A. S., & Brown, S. A. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-996-0035-x · Cited by 8
Subjective experience of diagnosis and treatment in two adolescents with first-episode schizophrenia
Abarzúa, M., Venegas, F., & Hidalgo, X. (2016) · Research in Psychotherapy Psychopathology Process and Outcome · doi:10.4081/ripppo.2016.189 · Cited by 10
Psychoeducational Interventions for People with Schizophrenia: Findings from the Systematic Reviews
Hasan, A. A., & Belkum, C. V. (2019) · Issues in Mental Health Nursing · doi:10.1080/01612840.2018.1509405 · Cited by 8
Dhavale, H. S., Pinto, C., Dass, J., Nayak, A., KEDARE, J., KAMAT, M., & Dewan, M. J. (2004) · Journal of Psychiatric Practice · doi:10.1097/00131746-200405000-00011 · Cited by 8
Clashing Ideologies or Scientific Discourse?
Bola, J. R., & Mosher, L. R. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006966 · Cited by 8
Ziprasidone and Migraine Headache
Boeker, T. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1435-a · Cited by 8
Kovess–Masféty, V., de Almeida, J. M. C., Carta, M. G., Dubuis, J., Lacalmontie, E., Pellet, J., Roelandt, J.-L., Moreno‐Küstner, B., Walsh, D., & Wiersma, D. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2005.02.007 · Cited by 8
Magliano, L., Fiorillo, A., Malangone, C., Rosa, C. D., Favata, G., Sasso, A., Prezioso, M., Pezzenati, L., Gentile, F., Casale, L., et al. (2005) · Epidemiology and Psychiatric Sciences · doi:10.1017/s1121189x00007983 · Cited by 8
Quality of Public Sector Care for Schizophrenia in Arkansas
Fischer, E. P., & Owen, R. R. (1999) · Mental Health Services Research · doi:10.1023/a:1022321407522 · Cited by 8
Perspective: Managed Care And Clinical Reality In Schizophrenia Treatment
Sharfstein, S. S., Boronow, J. J., & Dickerson, F. (1999) · Health Affairs · doi:10.1377/hlthaff.18.5.66 · Cited by 8
Metadata
- Authors
- Lehman, A. F., Steinwachs, D. M., & The Co-Investigators of the PORT Project
- Affiliations
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Corresponding author
- Lehman, A. F.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-01-01
- Volume
- 24
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2121113553
- Cited by
- 910
- References
- 14
- Citations by year
- 2025: 6 · 2024: 5 · 2023: 4 · 2022: 9 · 2021: 11 · 2020: 8 · 2019: 12 · 2018: 23 · 2017: 12 · 2016: 17 · 2015: 14 · 2014: 16 · 2013: 22 · 2012: 41
- FWCI
- 38.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Bulletin (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia
- MeSH terms
- Combined Modality Therapy, Health Policy, Humans, Research Support as Topic, Schizophrenia, United States, United States Agency for Healthcare Research and Quality, Treatment Outcome, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review